How Is the Gliclazide Challenge Test Used for MODY?

Being asked to undergo specialized diagnostic testing can feel overwhelming, especially when trying to pinpoint the exact type of diabetes you have. A gliclazide challenge test is an optional clinical procedure used to see how your pancreas responds to a specific diabetes medication called a sulfonylurea (such as gliclazide).

This test is not a routine evaluation for everyone, but an additional investigative step some doctors use. During the test, you take a dose of gliclazide, and your medical team monitors your blood sugar and C-peptide levels to check for a larger-than-expected increase in insulin production ^[1].

The procedure is sometimes used during the diagnostic process for Maturity-Onset Diabetes of the Young (MODY). People with certain types of MODY—specifically HNF1A-MODY and HNF4A-MODY, which refer to mutations in different genes—can be particularly sensitive to sulfonylureas ^[2][3].

Why Might Your Doctor Order This Test?

Often, people with MODY are initially misdiagnosed with Type 1 or Type 2 diabetes. While clinical assessment, antibody testing, and genetic testing are the standard evaluation methods, a gliclazide challenge test is an optional adjunct (additional tool) used in certain situations ^[1].

• Checking for functional beta cells: Beta cells are the cells in your pancreas that make insulin. In Type 1 diabetes, the immune system generally destroys these cells, meaning they produce little insulin ^[4]. A strong response to the challenge shows your beta cells are still functioning ^[4]. However, this does not rule out Type 1 diabetes completely, as some people retain insulin production early in the disease (sometimes called the “honeymoon phase”).
• Identifying sulfonylurea sensitivity: The test helps determine if your pancreas can release insulin when stimulated specifically by a sulfonylurea medication ^[4]. People with Type 2 diabetes might also respond, but a very strong response may increase suspicion of HNF1A- or HNF4A-MODY.
• Guiding future treatment plans: If the test shows a strong response, it may support consideration that your body might manage blood sugar using oral sulfonylurea pills instead of insulin injections ^[5][1].

⚠️ SAFETY WARNING: Never Stop Insulin on Your Own
A strong response to this test does NOT mean you can safely stop taking insulin. Stopping insulin without a strict, doctor-supervised transition plan can lead to dangerous high blood sugar and a life-threatening condition called Diabetic Ketoacidosis (DKA). Any transition in medication must be directed by your diabetes care team with close monitoring of glucose and ketones.

How the Test Works and What to Expect

Protocols for this test vary by clinic, but generally, here is what happens:

1. Baseline Testing: You will likely have blood drawn before taking the medication to check your baseline glucose and C-peptide levels.
2. Taking the Medication: You will be given a specific dose of gliclazide by the clinical staff. Do not attempt this at home or use leftover medication.
3. Serial Blood Draws: Over a few hours, your blood will be drawn at specific intervals to measure C-peptide alongside your blood glucose ^[1].
   • Why C-peptide? C-peptide is released in roughly equal amounts alongside insulin when your beta cells process it ^[6]. Because it stays in the blood longer, measuring a rise in C-peptide, interpreted with your simultaneous blood glucose level, gives a clearer picture of your own insulin production than measuring insulin directly ^[6]. Note that kidney function, diabetes duration, and your blood sugar at the time of the test all affect how C-peptide is interpreted.
4. Monitoring for Hypoglycemia: Because people with HNF1A- or HNF4A-MODY can be particularly sensitive to sulfonylureas, the test carries a risk of hypoglycemia (very low blood sugar) ^[7]. The clinic staff will watch you closely and treat you immediately if you experience symptoms like sweating, shaking, confusion, marked drowsiness, seizures, or loss of consciousness ^[7][1].

Before the Appointment Checklist

Follow your clinical team’s exact instructions regarding:

• Fasting: Ask if you need to arrive fasting or eat beforehand.
• Medications: Disclose all glucose-lowering medicines, including your current insulin doses. Ask exactly which medications to hold or continue on the morning of the test.
• Other Health Factors: Mention if you are pregnant, have a history of severe hypoglycemia, or have kidney or liver disease.

Understanding the Results

While a larger-than-expected rise in C-peptide is an excellent clue, it is not a diagnosis ^[1]. Molecular genetic testing (a blood or saliva test that looks at your DNA) is still required to confirm if you have MODY and exactly which gene is affected ^[8][1]. Because responses can vary based on your specific genetic variant, weight, and how long you’ve had diabetes, a modest response does not automatically rule out MODY ^[9][10].